Summary
Deficient natural killer (NK) cell activity may contribute to the development of distant metastases in the head and neck cancer patient. A total of 246 previously untreated patients expressed deficient NK activity against K562 target cells when compared to 110 age-matched healthy controls (70±48 lytic units (LU) versus 95±52 LU) (P<0.001). Some 164 consecutive patients have undergone definitive therapy subsequent to NK cell assessment and have been followed for a minimum of 12 months (median=16 months), and 23 have developed recurrent disease in distant sites. The risk of subsequently (1) developing distant metastases, (2) developing regional metastases, and (3) dying of progressive cancer was inversely related to pretreatment NK LU values (P<0.02, <0.02, <0.005, respectively, by the Cox proportional hazards model). NK cell function within the peripheral blood of the patient with head and neck cancer could be related to the percentage of Leu 11+ NK cell subsets (P<0.01 by linear regression analysis) as determined by both single-parameter and multiparameter flow cytometric assessment. Contrastingly, no relationship could be identified between NK function with the percentage of circulating Leu 7+ cell subsets. In vitro measured NK cell function identifies a population at increased risk for developing distant metastases, thus supporting the role of natural immunity as defense mechanism against blood-borne disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abo T, Miller CA, Balch CM (1984) Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates, and adults. Eur J Immunol 14:616
Balch CM, Dougherty FP, Tilden A (1982) Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients. Ann Surg 196:645
Barlozzari T, Reynolds CW, Herberman RB (1983) In vivo role of natural killer cells: Involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo DM-treated rats. J Immunol 131:1024
Beahrs OH, Myers MH (eds) (1983) American Joint Committee on Cancer. Part II: Staging of cancer at specific anatomic sites. Manual for staging of cancer. J. B. Lippincott, Philadelphia
deVilliers E, Weideauer OH, zur Hausen H (1985) Papilloma virus DNA in human tongue carcinomas. Int J Cancer 36:575
Ferson M, Edwards A, Lind A, et al. (1979) Low natural killer cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 23:603
Gorlik E, Wiltrout RH, Okumura K, Habu S, Herberman RB (1982) Role of NK cells in the control of metastatic spread of tumor cells in mice. Int J Cancer 30:107
Hanna N (1982) Role of natural killer cell in control of cancer metastasis. Cancer Metastasis Rev 1:45
Hersey P, Edwards A, Milton GW, McCarthy WH (1982–84) No evidence for an association between natural killer cell activity and prognosis in melanoma patients. Nat Immun Cell Growth Regul 3:87
Introna M, Mantovani A (1983) Natural killer cells in human solid tumors. Cancer Metastasis Rev 2:337
Karsh J, Doreal G, Osterland CK (1981) Natural cytotoxicity in rheumatoid arthritis and systemic lupus euythematosus. Clin Immunol Immunopathol 19:437
Katz AE (1983) Immunobiologic staging of patients with carcinoma of the head and neck. Laryngoscope 93:445
Komiyama K, Crago SS, Itoh K, Moro I, Mastecky J (1986) Inhibition of natural killer cell activity by IgA. Cell Immunol 101:143
Koren HS, Anderson SJ, Fischer DG, Copeland CS, Jensen PJ (1981) Regulation of human natural killing. I The role of monocytes, interferon, and prostaglandins. J Immunol 127:2007
Lanier LL, Warner NL (1981) Paraformaldehyde fixation of hematopoietic cells for quantitative flow cytometry (FACS) analysis. J Immunol Methods 47:25
Lanier LL, Le AM, Phillips JH, Warner NL, Bacock GF (1983) Subpopulations of human natural killer cells defined by expression of the Leu 8 (HNK-1) and Leu 11 (NK-15) antigens. J Immunol 131:1789
Okumura T, Kudo J, Ikuta T, Kurokawa S, Ishibaski H, Okubo H (1985) Influence of acute-phase proteins in the activity of natural killer cells. Inflammation 9:211
Perussia B, Acuto O, Terhorst C, Faust J, Lazarus R, Fanning V, Trinchieri G (1982) Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane. J Immunol 103:2142
Pollack SB, Hollenbeck LA (1982) In vivo reduction of NK activity withh anti-NK1 serum: Direct evaluation of NK cells in tumor clearance. Int J Cancer 29:203
Pross HF, Baines MG (1976) Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. I. The effect of malignant disease. Int J Cancer 18:593
Pross HT, Baines MG, Rubin P, Shragge P, Patterson MS (1981) Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol 1:51
Saxena QB, Mexey E, Adler WH (1980) Regulation of natural killer cell activity in vivo: II. The effect of alcohol consumption on human peripheral blood natural killer activity. Int J Cancer 26:413
Schantz SP, Poisson L (1986) Natural killer cell response to regional lymph node metastases. Arch Otolaryngol 112:545
Schantz SP, Romsdahl MM, Babcock GF, Nishioka K, Goepfert H (1985) The effect of surgery on natural killer cell activity in head and neck cancer patients: In vitro reversal of a postoperatively suppressed immunosurveillance system. Laryngoscope 95:588
Schantz SP, Brown B, Schwartz B (1986) NK cell activity, prognosis, and head and neck cancer. Proc Am Soc Clin Oncol 5:223
Schantz SP, Shillitoe EJ, Brown B, Campbell B (1986) Natural killer cell activity and head and neck cancer: A clinical assessment. J Natl Cancer Inst 77:869
Shillitoe EJ, Silverman S (1979) Oral cancer and herpes simplex virus: A review. Oral Surg 48:216
Shillitoe EJ, Greenspan D, Greenspan JS, Silverman S (1983) Immunoglobulin class of antibody to herpes simplex virus in patients with oral cancer. Cancer 51:65
Steinhauer EH, Doyole AT, Reed J, Kadish AS (1982) Defective natural cytotoxicity in patients with cancer: Normal number of effector cells but decreased recycling capacity in patients with advanced disease. J Immunol 129:2255
Takasugi M, Ramseyer A, Takasugi J (1977) Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res 37:413
Timonen T, Ortaldo JR, Herberman RB (1981) Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153:569
Trinchieri G, Perussia B (1984) Human natural killer cells: Biologic and pathologic aspects. Lab Invest 5:489
Veltri RW, Rodman SM, Maxim PE, Baseler MW, Sprinkle PM (1986) Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck. Cancer 57:2295
Virkram B, Strong WE, Shah JP (1984) Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg 6:730
Wasson JH, Sox HC, Neff RK, Goldman L (1985) Clinical prediction rules. Applications and methodological standards. N Engl J Med 313:793
Watanabe T, Iglehart JD, Bolognesi DP, Cox EB, Vaughn A, Hudson WP (1983) Elevated serum secretory immunoglobulin A levels in patients with head and neck carcinoma. Otolaryngol Head Neck Surg 91:136
Welsh RM (1981) Natural cell mediated immunity during virus infection. In: Haller O (ed) Natural resistance to tumors and viruses. Springer-Verlag, Berlin, p 981
Wolf GT, Chretien PB, Elias EG et al. (1979) Serum glycoproteins in head and neck squamous carcinoma correlates with tumor extent, clinical tumor stage and T-cell levels during chemotherapy. Am J Surg 138:489
zur Hausen H (1982) Human genital cancr: Synergysm between two virus infections or synergism between a virus infection and initiating events. Lancet II:1370
Author information
Authors and Affiliations
Additional information
Funded in part by a grant from the Kimberly-Clark Corporation and by grant CA16672 awarded by The National Cancer Institute, Department of Health and Human Services
Rights and permissions
About this article
Cite this article
Schantz, S.P., Brown, B.W., Lira, E. et al. Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunol Immunother 25, 141–145 (1987). https://doi.org/10.1007/BF00199955
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199955